WHO ICTRP trial
Comparing effect of Dexmedetomidine and Labetalol on Intraoperative blood loss…
IRCT20150317021497N7 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20150317021497N7 |
|---|---|
| Public title | Comparing effect of Dexmedetomidine and Labetalol on Intraoperative blood loss in Rhinoplasty |
| Scientific title | Comparing effect of Dexmedetomidine and Labetalol on Intraoperative blood loss and surgical field quality in Rhinoplasty: A double-Blinded Clinical Trial |
| Primary sponsor | Rafsanjan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Condition 1: Systolic blood pressure. Condition 2: Diastolic blood pressure. Condition 3: Heart rate per minute. Condition 4: Mean arterial pressure. Condition 5: Bleeding rate. Elevated blood-pressure reading, without diagnosis of… |
| Interventions | Intervention 1: Intervention group: Dexmedetomidine in the form of a vial of 200 micrograms in 2 cc has a sympatholytic effect and is used as an infusion at a dose of 1 microgram per kilogram of body weight in 100 cc of normal saline to… |
| Registration date | Jul 16, 2022 |
| Target size | 30 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: